Perathiepin
Clinical data | |
---|---|
ATC code |
|
Identifiers | |
IUPAC name
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C19H22N2S |
Molar mass | 310.46 g·mol−1 |
3D model (JSmol) | |
SMILES
| |
InChI
|
Perathiepin is a neuroleptic drug of the tricyclic family which was developed in the 1960s but was never marketed. In animal studies it was found to possess central depressant, antihistamine, antiserotonergic, and analgesic effects.[1][2]
See also
References
- ↑ Rosowsky A (1972). Chemistry of heterocyclic compounds. John Wiley & Sons. pp. 796–797. ISBN 978-0-471-38210-2. Retrieved 26 November 2011.
- ↑ Harbert CA, Welch MW (1 September 1974). "Antipsychotic and Antianxiety Agents". In Henzelmann RV, Gordon M (eds.). Annual Reports in Medicinal Chemistry. Vol. 9. Academic Press. pp. 1–10 (2). doi:10.1016/S0065-7743(08)61422-0. ISBN 978-0-12-040509-1. Retrieved 26 November 2011.
Classes |
|
---|---|
Antidepressants (TCAs and TeCAs) |
|
Antihistamines |
|
Antipsychotics |
|
Anticonvulsants | |
Others |
|
This article is issued from Offline. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.